Avodart (dutasteride) May Prevent Prostate Cancer
Avodart (dutasteride) may both prevent prostate cancer and improve the predictive power of the blood test, PSA, according to researchers from the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia. In their recent study of men with benign prostatic hyperplasia (BPH), the medication was associated with a 40% lower incidence of prostate cancer diagnosis than the BPH drug tamsulosin (Flomax) in at-risk men.
Several other trials have also found similar results. The American Society of Clinical Oncology and American Urological Association recommends that healthy older men discuss this with their doctors.
About Benign Prostatic Hyperplasia (BPH)
Source: “Prostate CA Prevention Affirmed for BPH Drug”, MedPage Today, March 07, 2010
Gomella LG, et al “Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia in the combination of dutasteride and tamsulosin (CombAT) trial” ASCO GU 2010; Abstract 28.
Bookmark this page
E-mail this story
Print this post
0 Responses to “Avodart (dutasteride) May Prevent Prostate Cancer”